Inflammatory Biomarkers in Addictive Disorders

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2021 Dec 24

PMID 34944470

Citations 19

Authors

Alvaro Morcuende

Francisco Navarrete

Elena Nieto

Jorge Manzanares

Teresa Femenia

Affiliations

Soon will be listed here.

Abstract

Substance use disorders are a group of diseases that are associated with social, professional, and family impairment and that represent a high socio-economic impact on the health systems of countries around the world. These disorders present a very complex diagnosis and treatment regimen due to the lack of suitable biomarkers supporting the correct diagnosis and classification and the difficulty of selecting effective therapies. Over the last few years, several studies have pointed out that these addictive disorders are associated with systemic and central nervous system inflammation, which could play a relevant role in the onset and progression of these diseases. Therefore, identifying different immune system components as biomarkers of such addictive disorders could be a crucial step to promote appropriate diagnosis and treatment. Thus, this work aims to provide an overview of the immune system alterations that may be biomarkers of various addictive disorders.

Citing Articles

Changes in Concentration of Selected Biomarkers of Exposure in Users of Classic Cigarettes, E-Cigarettes, and Heated Tobacco Products-A Narrative Review.

Sniadach J, Kicman A, Michalska-Falkowska A, Jonczyk K, Waszkiewicz N Int J Mol Sci. 2025; 26(5).

PMID: 40076424 PMC: 11898610. DOI: 10.3390/ijms26051796.

Characterization of serum and brain cytokine levels following prolonged binge-like methamphetamine self-administration and cued methamphetamine seeking.

Acuna A, Nagy E, Legg J, Rodarte S, Olive M J Neuroimmunol. 2025; 400:578530.

PMID: 39854936 PMC: 11875959. DOI: 10.1016/j.jneuroim.2025.578530.

Neurological impact of HIV/AIDS and substance use alters brain function and structure.

Haorah J, Malaroviyam S, Iyappan H, Samikkannu T Front Med (Lausanne). 2025; 11:1505440.

PMID: 39839621 PMC: 11747747. DOI: 10.3389/fmed.2024.1505440.

Increased white blood cell in young adults with family histories of alcohol and other substance use disorders.

Mithaiwala M, Phillips N, Nguyen D, Beehler M, Ballard H, Vincent A Addict Biol. 2024; 29(11):e70000.

PMID: 39558659 PMC: 11574109. DOI: 10.1111/adb.70000.

Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the dorsolateral prefrontal cortex.

MacDonald M, Fonseca P, Johnson K, Murray E, Kember R, Kranzler H Transl Psychiatry. 2024; 14(1):437.

PMID: 39402051 PMC: 11473550. DOI: 10.1038/s41398-024-03143-z.

References

Maes M, Lin A, Bosmans E, Vandoolaeghe E, Bonaccorso S, Kenis G . Serotonin-immune interactions in detoxified chronic alcoholic patients without apparent liver disease: activation of the inflammatory response system and lower plasma total tryptophan. Psychiatry Res. 1998; 78(3):151-61. DOI: 10.1016/s0165-1781(98)00010-9. View

Lacagnina M, Kopec A, Cox S, Hanamsagar R, Wells C, Slade S . Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats. Neuropsychopharmacology. 2017; 42(11):2128-2140. PMC: 5603817. DOI: 10.1038/npp.2017.82. View

Sun Z, Chang B, Huang A, Hao S, Gao M, Sun Y . Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease. J Cell Mol Med. 2018; 23(2):887-897. PMC: 6349182. DOI: 10.1111/jcmm.13990. View

Dennis B, Samaan M, Bawor M, Paul J, Plater C, Pare G . Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat. 2014; 10:2239-47. PMC: 4242695. DOI: 10.2147/NDT.S72785. View

Zhang X, Yu H, Bai R, Ma C . Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis. Front Neurosci. 2020; 14:608349. PMC: 7729193. DOI: 10.3389/fnins.2020.608349. View

Keen 2nd L, Turner A . Association between interleukin-6 and neurocognitive performance as a function of self-reported lifetime marijuana use in a community based sample of African American adults. J Int Neuropsychol Soc. 2014; 20(8):773-83. DOI: 10.1017/S1355617714000691. View

Erickson E, Grantham E, Warden A, Harris R . Neuroimmune signaling in alcohol use disorder. Pharmacol Biochem Behav. 2018; 177:34-60. PMC: 6946054. DOI: 10.1016/j.pbb.2018.12.007. View

Kohno M, Link J, Dennis L, McCready H, Huckans M, Hoffman W . Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacol Biochem Behav. 2019; 179:34-42. PMC: 6637953. DOI: 10.1016/j.pbb.2019.01.007. View

Saad M, Rumschlag M, Guerra M, Savonen C, Jaster A, Olson P . Differentially expressed gene networks, biomarkers, long noncoding RNAs, and shared responses with cocaine identified in the midbrains of human opioid abusers. Sci Rep. 2019; 9(1):1534. PMC: 6367337. DOI: 10.1038/s41598-018-38209-8. View

10.

Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

11.

Garcia-Gutierrez M, Navarrete F, Sala F, Gasparyan A, Austrich-Olivares A, Manzanares J . Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. Front Psychiatry. 2020; 11:432. PMC: 7243207. DOI: 10.3389/fpsyt.2020.00432. View

12.

BALDWIN G, Tashkin D, Buckley D, Park A, Dubinett S, Roth M . Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med. 1997; 156(5):1606-13. DOI: 10.1164/ajrccm.156.5.9704146. View

13.

Ramsay H, Surcel H, Bjornholm L, Kerkela M, Khandaker G, Veijola J . Associations Between Maternal Prenatal C-Reactive Protein and Risk Factors for Psychosis in Adolescent Offspring: Findings From the Northern Finland Birth Cohort 1986. Schizophr Bull. 2020; 47(3):766-775. PMC: 8084441. DOI: 10.1093/schbul/sbaa152. View

14.

Franklin T, Xu C, Duman R . Depression and sterile inflammation: Essential role of danger associated molecular patterns. Brain Behav Immun. 2017; 72:2-13. DOI: 10.1016/j.bbi.2017.10.025. View

15.

Vancampfort D, Hallgren M, Mugisha J, De Hert M, Probst M, Monsieur D . The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis. Alcohol Alcohol. 2016; 51(5):515-21. DOI: 10.1093/alcalc/agw040. View

16.

Hsuchou H, Kastin A, Mishra P, Pan W . C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation. Cell Physiol Biochem. 2012; 30(5):1109-19. PMC: 4099000. DOI: 10.1159/000343302. View

17.

Bala S, Marcos M, Gattu A, Catalano D, Szabo G . Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS One. 2014; 9(5):e96864. PMC: 4020790. DOI: 10.1371/journal.pone.0096864. View

18.

Massi P, Sacerdote P, Ponti W, Fuzio D, Manfredi B, Vigano D . Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters. J Neuroimmunol. 1999; 92(1-2):60-6. DOI: 10.1016/s0165-5728(98)00177-5. View

19.

Namba M, Leyrer-Jackson J, Nagy E, Olive M, Neisewander J . Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities. Front Neurosci. 2021; 15:650785. PMC: 8082184. DOI: 10.3389/fnins.2021.650785. View

20.

OSullivan S, Malahias E, Park J, Srivastava A, Reyes B, Gorky J . Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis. Front Neurosci. 2019; 13:665. PMC: 6619439. DOI: 10.3389/fnins.2019.00665. View